Furthermore, a lot of perfectly proven adverse prognostic markers, together with U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their adverse influence in patients treated with VO. The one variable that remained predictive of the shorter development-totally free survival In this particular cohort of individuals was TP53 aberrations.112